Leptomeningeal Carcinomatosis
📧 Sign up to get email alerts when something new happens for Leptomeningeal Carcinomatosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV) [Phase 1]
First-in-human, dose-escalation Phase 1 study of a dendritic cell vaccine (DCV) is underway, with recruitment for leptomeningeal carcinomato…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: CSF and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and CNS Metastases or no CNS Metastases [NA]
A clinical trial evaluating CSF and blood plasma liquid biopsy in patients with metastatic solid tumors, with and without brain metastases o…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
This clinical trial update notes ongoing recruitment for a study at MD Anderson evaluating patient perceptions of quality of care delivered …
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating hippocampal avoidance in craniospinal irradiation for leptomeningeal metastases from breast cancer or no…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating photon craniospinal irradiation for leptomeningeal metastases arising from breast cancer or non-small ce…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases [Phase 2]
A Phase 2 trial update describing a novel combination of intrathecal pemetrexed with high-dose furmonertinib and bevacizumab for EGFR-mutant…